$0.99 +0.05 (5.64%)

agilon health, inc. (AGL)

Agilon Health, Inc. (AGL) is a healthcare company focused on partnering with primary care physicians to deliver value-based care. The company provides technology, data analytics, and administrative support to help physicians improve patient outcomes, reduce costs, and transition to value-driven healthcare models. Agilon aims to reshape primary care delivery through innovative healthcare solutions and sustainable model integration.

Dividend Yield 44.65%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
July 3, 2008$0.112008-06-202008-06-24
April 4, 2008$0.112008-03-242008-03-26
January 3, 2008$0.112007-12-182007-12-20
October 12, 2007$0.112007-09-282007-10-02
July 3, 2007$0.112007-06-192007-06-21

Dividends Summary

Company News

AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc. • Rosen Law Firm • October 17, 2025

Rosen Law Firm is investigating potential securities claims for agilon health shareholders after the company suspended its 2025 financial guidance, causing a 51.5% stock price drop on August 5, 2025.

AGILON HEALTH INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL
Benzinga • Business Wire • September 26, 2025

Law firm Kahn Swick & Foti is investigating Agilon Health's officers and directors after the company lowered its 2023 profit forecasts and faced a securities class action lawsuit alleging failure to disclose material information.

5 Stocks Under $10 With Double-Digit Fair Value Upside Potential
Investing.com • Jesse Cohen • March 7, 2025

This article highlights 5 stocks trading under $10 that have significant double-digit upside potential based on their fair value estimates. The companies include IHS Holding, Melco Resorts & Entertainment, Inter & Co, Janus International Group, and Agilon Health.

Agilon (AGL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research • Zacks Equity Research • May 7, 2024

Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Asset Class And Stock Performance Since 10/27/23
Seeking Alpha • Bespoke Investment Group • February 17, 2024

Since October 27th (less than four months ago), the S&P 500 ETF (SPY) is now up 22.8%. That's a big move.